Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-021245

Chief Executive Officer sold 5,000 shares at $11.53 ($57,635)

  • Chief Executive Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2024-08-12 Option exercise 10b5-1 +5,000 $2.33 $11,650 125,695 D
Townsend Richard Nolan Chief Executive Officer 2024-08-12 Sale 10b5-1 −5,000 $11.53 $57,635 120,695 D
Derivatives
Townsend Richard Nolan Chief Executive Officer 2024-08-12 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 133,655 D
Open-market sales · 5,000 sh · avg $11.53 · $57,635
Loading xslF345X05/form4-08132024_100801.xml…